Back to UBS Group AG UBS Group AG

QNTMQNTM
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in QUANTUM BIOPHARMA LTD

Yes. Ubs holds 33,405 shares of QNTM (Quantum Biopharma), worth $120,926, as of its Q2 2026 13F filing. It increased the position from 7,237 shares in Q1 2026. Ubs has held QNTM since Q1 2025, across 6 quarterly 13F filings.

Current Value

$120,926

Current Shares

33,405

Total Value Change

+$108,482

Total Shares Change

+31,791

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
33,405
+361.6%
$120,9260.0%$3.62
24
2026-Q1
Increased
7,237
+323.2%
$34,9550.0%$4.83
22
2025-Q4
Decreased
1,710
-80.5%
$12,4830.0%$7.30
0
2025-Q3
Decreased
8,754
-80.9%
$143,5660.0%$16.40
0
2025-Q2
Increased
45,883
+2742.8%
$929,1310.0%$20.25
40
2025-Q1
New
1,614
-
$12,4440.0%$7.71
27

Other major holders of QNTM: Virtu Financial LLC, LPL Financial LLC, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used